Megestrol Acetate for Heavily Pretreated Metastatic Castration-Resistant Prostate Cancer: An Old Answer for a New Problem

Prostate cancer is the most frequent malignant tumor in male. Despite its incidence increased in the last few years, the mortality is gradually decreasing, even in patients with metastatic prostate cancer (mPC). Unfortunately, prolongation of survival leads to the exhaustion of therapeutic chances....

Descripción completa

Detalles Bibliográficos
Autores principales: La Vecchia, Maria, Galanti, Daniele, Fazio, Ivan, Paratore, Rosario, Borsellino, Nicolò
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035953/
https://www.ncbi.nlm.nih.gov/pubmed/35529294
http://dx.doi.org/10.1159/000522086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035953/
https://www.ncbi.nlm.nih.gov/pubmed/35529294
http://dx.doi.org/10.1159/000522086

Ejemplares similares